Steven Cohen's ADCT Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 3.38 M shares of ADC Therapeutics SA (ADCT) worth $12.68 M, representing 0.02% of the portfolio. First purchased in 2022-Q4, this short-term holding has been held for 6 quarters.
Based on 13F filings, Steven Cohen has maintained this position in ADCT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 7.76 M shares. Largest reduction occurred in Q4 2025, reducing 3.12 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's ADC Therapeutics (ADCT) Holding Value Over Time
Track share changes against reported price movement
Quarterly ADC Therapeutics (ADCT) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -1.63 M | Reduce 32.55% | 3.38 M | $3.75 |
| Q4 2025 | -3.12 M | Reduce 38.36% | 5.01 M | $3.53 |
| Q3 2025 | +371,993 | Add 4.79% | 8.14 M | $4.00 |
| Q2 2025 | +7.76 M | New Buy | 7.76 M | $2.68 |
| Q1 2023 | -704,500 | Sold Out | 0 | $0.00 |
| Q4 2022 | +704,500 | New Buy | 704,500 | $3.84 |
Steven Cohen's ADC Therapeutics Investment FAQs
Steven Cohen first purchased ADC Therapeutics SA (ADCT) in Q4 2022, acquiring 704,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held ADC Therapeutics SA (ADCT) for 6 quarters since Q4 2022.
Steven Cohen's largest addition to ADC Therapeutics SA (ADCT) was in Q2 2025, adding 7,763,658 shares worth $20.81 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 3,382,129 shares of ADC Therapeutics SA (ADCT), valued at approximately $12.68 M.
As of the Q1 2026 filing, ADC Therapeutics SA (ADCT) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in ADC Therapeutics SA (ADCT) was 8,135,651 shares, as reported at the end of Q3 2025.